BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23230703)

  • 1. Eligibility and take-up of the Medicare Part D low-income subsidy.
    Shoemaker JS; Davidoff AJ; Stuart B; Zuckerman IH; Onukwugha E; Powers C
    Inquiry; 2012; 49(3):214-30. PubMed ID: 23230703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility for the Medicare buy-in programs, based on a survey of income and program participation simulation.
    Rupp K; Sears J
    Soc Secur Bull; 2000; 63(3):13-25. PubMed ID: 11439702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
    Kuye IO; Frank RG; McWilliams JM
    JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using matched survey and administrative data to estimate eligibility for the Medicare Part D low-income subsidy program.
    Meijer E; Karoly LA; Michaud PC
    Soc Secur Bull; 2010; 70(2):63-82. PubMed ID: 20560303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use.
    Fung V; Price M; Cheng D; Patel TA; Yang Z; Hsu J; Alegria M; Newhouse JP
    JAMA Health Forum; 2024 Feb; 5(2):e235152. PubMed ID: 38306091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
    Wei II; Lloyd JT; Shrank WH
    J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
    Glynn A; Hernandez I; Roberts ET
    Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll.
    Loh FE; Stuart BC; Hunt RJ; Negari M
    J Manag Care Spec Pharm; 2024 Mar; 30(3):279-289. PubMed ID: 38324387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
    Briesacher BA; Ross-Degnan D; Wagner AK; Fouayzi H; Zhang F; Gurwitz JH; Soumerai SB
    Med Care; 2010 Jun; 48(6):503-9. PubMed ID: 20473197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare savings programs: analyzing options for expanding eligibility.
    Zuckerman S; Shang B; Waidmann T
    Inquiry; 2009-2010 Winter; 46(4):391-404. PubMed ID: 20184166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-income Medicare beneficiaries and their experiences with the part D prescription drug benefit.
    Rudolph NV; Montgomery MA
    Inquiry; 2010; 47(2):162-72. PubMed ID: 20812464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of the Medicare Part D Low-Income Subsidy among Older non-Hispanic Blacks and Hispanics.
    Bakk L; Cadet TJ
    Soc Work Public Health; 2018; 33(4):250-258. PubMed ID: 29694273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
    Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
    J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.
    Stuart B; Hendrick FB; Xu J; Dougherty JS
    Health Serv Res; 2017 Jun; 52(3):1185-1206. PubMed ID: 27324201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to Medicare drug costs among near-poor versus subsidized beneficiaries.
    Fung V; Reed M; Price M; Brand R; Dow WH; Newhouse JP; Hsu J
    Health Serv Res; 2013 Oct; 48(5):1653-68. PubMed ID: 23663197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unintended effects of the Medicare Part D low income subsidy.
    Decarolis F
    Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intelligent assignment to Medicare Part D plans for people with schizophrenia could produce substantial savings.
    Zhang Y; Baik SH; Newhouse JP
    Health Aff (Millwood); 2015 Mar; 34(3):455-60. PubMed ID: 25732496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare premium buy-in programs: results of SSA demonstration projects.
    Nadel M; Alecxih L; Parent R; Sears J
    Soc Secur Bull; 2000; 63(3):26-33. PubMed ID: 11439703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.